Quadriceps Tendon Versus Bone Patellar Tendon Bone Autograft ACL Reconstruction RCT
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jul 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different types of tissue grafts used to repair a common knee injury known as an anterior cruciate ligament (ACL) tear. Specifically, the study is comparing the use of a quadriceps tendon graft to a bone patellar tendon graft in patients undergoing ACL reconstruction surgery. This research aims to determine which type of graft may offer better outcomes for patients.
To participate in this trial, you need to be between 18 and 64 years old, have a confirmed ACL injury, and be scheduled for surgery that involves taking a graft from your own body. However, if you're younger than 14 or older than 65, or if you have other specific medical issues that could complicate surgery or recovery, you won't be eligible. If you join the study, you will receive one of the two types of grafts and will be monitored to see how well you recover. It's important to note that participants need to commit to following a physical therapy program after the surgery to help ensure the best recovery possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Skeletally mature patients younger 65
- • ACL insufficiency
- • Scheduled to undergo autograft ACL reconstruction
- • Appropriate candidate for autograft harvest
- Exclusion Criteria:
- • \<14 or 65\>
- • Poor autograft candidate (poor tissue quality)
- • Multi ligamentous reconstruction (PCL, MCL, or PLC)
- • Pregnant or nursing
- • High likelihood of remaining non-compliant with physical therapy regimen
- • Desire to return to sport prior to 6 months
- • Inability to read and write English
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Patients applied
Trial Officials
Amit Momaya, MD
Principal Investigator
Department of Orthopaedic Surgery, University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials